Document is current
Any future updates will be listed below
-
Authors
Bakshi, Nikul
Bale, Claire
Binu, Tincy
Brown, Graham
Calder, Jayne
Campbell, Richard
George, Helen
Gosden, Lesley
Hobbs, Andrew
Phipps, Thomas
Prettyman, Richard https://orcid.org/0009-0001-4908-1951
Roach, Arthur
Bodicoat, Danielle H. https://orcid.org/0000-0002-2184-4865
Whone, Alan https://orcid.org/0000-0002-8931-4422
-
Funding
Funding for this research was provided by:
Parkinson's UK
- License Information
-
More Information
Article History
Received: 27 July 2025
Accepted: 30 January 2026
First Online: 17 February 2026
Ethics approval and consent to participate
: Ethical approval was not obtained as this was a PPI project, rather than a research study.
: Not applicable.
: NB, CB, and AR are employees of Parkinson’s UK. NB is a Board member of Patient Focused Medicines Development. CB is a Board member of Parkinson’s Europe. DB has received consulting fees from Parkinson’s UK, University of Leicester, Lindus Health, and HEOR Value Hub. LG has received payment or honoraria for presenting from Britannia Pharmaceuticals and is an Advisory Board member for Parexel MMS Europe Limited. AR is a Director of Vivifi Biotech Limited. AW has received consulting fees from AskBio. The other authors have declared no competing interests.
